These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2682898)

  • 41. Treatment of severe reflux esophagitis with cimetidine and metoclopramide.
    Lieberman DA; Keeffe EB
    Ann Intern Med; 1986 Jan; 104(1):21-6. PubMed ID: 3940501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bismuth subsalicylate--an aid to the diagnosis and treatment of reflux esophagitis.
    Bernstein RK
    Diabetes Care; 1984; 7(4):404-5. PubMed ID: 6468241
    [No Abstract]   [Full Text] [Related]  

  • 43. Pirenzepine in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study.
    Niemelä S; Jääskeläinen T; Lehtola J; Martikainen J; Krekelä I; Sarna S; Sarelin H
    Scand J Gastroenterol; 1986 Dec; 21(10):1193-9. PubMed ID: 3544181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reflux esophagitis: effect of oral bethanechol on symptoms and endoscopic findings.
    Thanik KD; Chey WY; Shah AN; Gutierrez JG
    Ann Intern Med; 1980 Dec; 93(6):805-8. PubMed ID: 7004292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controlled trial comparing De-Nol tablets with De-Nol liquid in treatment of duodenal ulcer.
    Hamilton I; Axon AT
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):362. PubMed ID: 6780025
    [No Abstract]   [Full Text] [Related]  

  • 46. Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial.
    Baldi F; Bianchi Porro G; Dobrilla G; Iascone C; Lobello R; Marzio L; Sabbatini F; Tittobello A; Verme G
    J Clin Gastroenterol; 1988 Dec; 10(6):614-8. PubMed ID: 3068300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of colloidal bismuth (De-Nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up.
    Salmon PR; Brown P; Williams R; Read AE
    Gut; 1974 Mar; 15(3):189-93. PubMed ID: 4601523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cimetidine treatment of reflux esophagitis in children: an Italian multicentric study.
    Cucchiara S; Gobio-Casali L; Balli F; Magazzú G; Staiano A; Astolfi R; Amarri S; Conti-Nibali S; Guandalini S
    J Pediatr Gastroenterol Nutr; 1989 Feb; 8(2):150-6. PubMed ID: 2651632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Some effects of tripotassium dicitrato bismuthate on gastric secretion and the mucus barrier.
    Sidebotham RL; Batten JJ; Li K; Spencer J; Baron JH
    Aliment Pharmacol Ther; 1990 Oct; 4(5):535-46. PubMed ID: 2129641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of tripotassium dicitrato bismuthate with macrophages in the rat and in vitro.
    Soutar RL; Coghill SB
    Gastroenterology; 1986 Jul; 91(1):84-93. PubMed ID: 3710085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropsychiatric symptoms following bismuth intoxication.
    Weller MP
    Postgrad Med J; 1988 Apr; 64(750):308-10. PubMed ID: 3186575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate.
    Gavey CJ; Szeto ML; Nwokolo CU; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 1989 Feb; 3(1):21-8. PubMed ID: 2491455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Skin disorders caused by bismuth oxide (De-Nol)].
    Ottervanger JP; Stricker BH
    Ned Tijdschr Geneeskd; 1994 Jan; 138(3):152-3. PubMed ID: 8295642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proceedings: Effective treatment of gastric ulceration with a Bismuth preparation (De-Nol).
    Boyes BE; Woolf IL; Wilson RY; Cowley DJ; Dymock IW
    Gut; 1974 Oct; 15(10):833. PubMed ID: 4611754
    [No Abstract]   [Full Text] [Related]  

  • 55. D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.
    Nwokolo CU; Pounder RE
    Br J Clin Pharmacol; 1990 Oct; 30(4):648-50. PubMed ID: 2291879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute thrombocytopenia after De-Nol.
    Beckingham IJ; Baird G; Kesteven PJ
    Gut; 1989 Jul; 30(7):1016-7. PubMed ID: 2759482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Personal experience in TCM treatment of reflux esophagitis.
    Hong L
    J Tradit Chin Med; 2003 Sep; 23(3):175-6. PubMed ID: 14535176
    [No Abstract]   [Full Text] [Related]  

  • 58. De-Nol in the treatment of reflux esophagitis.
    Balan G; Săndulescu E; Cijevschi C; Stanciu R; Darwish R; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):67-70. PubMed ID: 2682898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Colloidal bismuth subcitrate tablets and placebo in chronic duodenal ulceration: a double-blind, randomised trial.
    Wilson P; Alp MH
    Med J Aust; 1982 Mar; 1(5):222-3. PubMed ID: 7045603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A controlled clinical trial with De-Nol (tripotassium dicitrato bismuthate) in patients with gastric ulcer.
    Patty I; Deák G; Jávor T; Mózsik G; Nagy L; Tárnok F
    Int J Tissue React; 1983; 5(4):397-401. PubMed ID: 6368445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.